SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $306,459 | -32.5% | 11,688 | -33.8% | 0.14% | -62.2% |
Q1 2023 | $454,234 | -49.8% | 17,647 | -49.3% | 0.37% | -31.1% |
Q4 2022 | $905,226 | +146.0% | 34,803 | +170.0% | 0.54% | +155.7% |
Q3 2022 | $368,000 | -21.7% | 12,888 | -32.5% | 0.21% | -26.1% |
Q2 2022 | $470,000 | +7.3% | 19,080 | +146.0% | 0.28% | +2.2% |
Q1 2022 | $438,000 | -60.5% | 7,755 | -56.6% | 0.28% | -68.5% |
Q4 2021 | $1,108,000 | +12.0% | 17,870 | +14.6% | 0.88% | +34.9% |
Q3 2021 | $989,000 | +12.9% | 15,594 | +46.7% | 0.65% | +5.3% |
Q2 2021 | $876,000 | +23.2% | 10,631 | +9.9% | 0.62% | +17.6% |
Q1 2021 | $711,000 | -21.0% | 9,669 | -22.1% | 0.53% | -8.2% |
Q4 2020 | $900,000 | +64.5% | 12,412 | +8.1% | 0.58% | +44.1% |
Q3 2020 | $547,000 | +22.4% | 11,477 | +7.8% | 0.40% | +7.8% |
Q2 2020 | $447,000 | – | 10,649 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |